IPAD-DB ID | D00161 |
Name | 1,2-dimethylhydrazine |
Category | Drugs |
2D Structure |
|
3D Structure | |
Molecular Formula | C 2 H 8 N 2 |
Molecular Weight | 60.10 |
IUPAC Name | 1,2-dimethylhydrazine |
InChI | InChI=1S/C2H8N2/c1-3-4-2/h3-4H,1-2H3 |
InChIKey | DIIIISSCIXVANO-UHFFFAOYSA-N |
Canonical SMILES | CNNC |
PubChem CID | 1322 |
DrugBank Accession Number | - |
CAS Registry Number | - |
Ki | - |
EC50 | - |
IC50 | - |
Inhibition | - |
Toxicity | - |
ROS(reactive oxygen species) | - |
Metal Chelating | - |
BBB(blood-brain barrier) | - |
Target Protein | Aβ |
Effects | - |
Research Models | - |
Ref. Link |
Molecular Weight(Computed by SwissADME) | 60.1 |
Hac(Computed by SwissADME) | 4 |
Volume(Computed by ADMETlab 2.0) | 65.142 |
Density(Computed by ADMETlab 2.0) | 0.922 |
nRing(Computed by ADMETlab 2.0) | 0 |
MaxRing(Computed by ADMETlab 2.0) | 0 |
nHet(Computed by ADMETlab 2.0) | 2 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 0 |
Flexibility(Computed by ADMETlab 2.0) | inf |
Stero Centers(Computed by ADMETlab 2.0) | 0 |
LogS(Computed by ADMETlab 2.0) | 1.062 |
LogD(Computed by ADMETlab 2.0) | -1.042 |
logP(Computed by ADMETlab 2.0) | -0.554 |
TPSA(Computed by SwissADME) | 24.06 |
Hbond Acceptor(Computed by SwissADME) | 2 |
Hbond Donor(Computed by SwissADME) | 2 |
Rotatable Bonds(Computed by SwissADME) | 1 |
GI Absorption(Computed by SwissADME) | Low |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No |
P-gp Substrate(Computed by SwissADME) | No |
CYP1A2 Inhibitor(Computed by SwissADME) | No |
CYP2C19 Inhibitor(Computed by SwissADME) | No |
CYP2C9 Inhibitor(Computed by SwissADME) | No |
CYP2D6 Inhibitor(Computed by SwissADME) | No |
CYP3A4 Inhibitor(Computed by SwissADME) | No |
log Kp(Skin Permeation)(Computed by SwissADME) | -6.98 |
Lipinski(Computed by SwissADME) | 0 |
Ghose(Computed by SwissADME) | 4 |
Veber(Computed by SwissADME) | 0 |
Egan(Computed by SwissADME) | 0 |
Muegge(Computed by SwissADME) | 2 |
Bioavailability Score(Computed by SwissADME) | 0.55 |